New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis

Mar Drugs. 2014 Dec 29;13(1):128-40. doi: 10.3390/md13010128.

Abstract

A bioassay guided fractionation of the ethyl acetate extract from culture broths of the strain Streptomyces zhaozhouensis CA-185989 led to the isolation of three new polycyclic tetramic acid macrolactams (1-3) and four known compounds. All the new compounds were structurally related to the known Streptomyces metabolite ikarugamycin (4). Their structural elucidation was accomplished using a combination of electrospray-time of flight mass spectrometry (ESI-TOF MS) and 1D and 2D NMR analyses. Compounds 1-3 showed antifungal activity against Aspergillus fumigatus, Candida albicans and antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / pharmacology*
  • Aspergillus fumigatus / drug effects
  • Candida albicans / drug effects
  • Lactams / isolation & purification*
  • Lactams / pharmacology
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Spectrometry, Mass, Electrospray Ionization
  • Streptomyces / chemistry*

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Lactams
  • ikarugamycin